HSC Biology Module 7 Infectious Disease: deep dive on pathogens, immunity and epidemiology

What Module 7 actually demands

Module 7 (Infectious Disease) is the most marker-heavy module in HSC Biology. Combined with Module 8, it accounts for roughly 60 percent of the exam. The content is dense: five pathogen groups, two arms of the immune system, several epidemiological measures, and a long list of named diseases and public health responses.

NESA frames the module around four inquiry questions, but in practice the exam consistently tests five clusters: pathogen types and transmission, the immune response, epidemiology, vaccination and public health, and antibiotic resistance. The recurring extended-response pattern asks you to choose a named disease, describe the pathogen and how it causes disease, describe the immune response, and evaluate one or more management strategies.

Pathogen groups, with named examples

A pathogen is any biological agent that causes disease. NESA recognises five groups.

Bacteria. Prokaryotic, single-celled organisms with a cell wall (peptidoglycan in most). Reproduce by binary fission. Cause disease through toxins (Clostridium tetani secretes tetanospasmin, causing tetanus) or by colonising and damaging host tissue (Mycobacterium tuberculosis colonises the lungs, causing tuberculosis). Treated with antibiotics targeting bacterial-specific structures (cell wall synthesis, ribosomes, DNA gyrase).

Viruses. Acellular particles consisting of nucleic acid (DNA or RNA) wrapped in a protein capsid, sometimes with a lipid envelope. Cannot replicate independently. Bind host cell receptors, inject genetic material, and hijack host machinery to produce viral progeny. Examples: influenza (RNA virus, mutates rapidly), HIV (retrovirus, integrates into host DNA, attacks helper T cells), SARS-CoV-2 (coronavirus, spike protein binds ACE2 receptor). Treated with specific antivirals; antibiotics do not work.

Prions. Misfolded proteins that induce other proteins to misfold. No nucleic acid. Cause spongiform encephalopathies. Example: bovine spongiform encephalopathy (BSE, mad cow disease), variant Creutzfeldt-Jakob disease in humans. Extremely resistant to denaturation by heat, chemicals, and radiation.

Fungi. Eukaryotic, single-celled (yeasts) or multicellular (moulds). Often opportunistic, causing disease in immunocompromised hosts or at surface sites. Examples: tinea (Trichophyton species, causing athlete's foot and ringworm), Candida albicans (causing thrush, particularly in immunosuppressed patients). Treated with antifungals.

Protozoa and multicellular parasites. Eukaryotic organisms ranging from single-celled (Plasmodium causing malaria; Giardia causing giardiasis) to multicellular (tapeworms, hookworms). Transmission is often vector-borne or via contaminated water. Treated with antiparasitic drugs.

For every group, learn at least one specific named disease, the transmission route, and one management strategy.

Transmission and entry

Direct transmission. Contact (touch, sexual contact), droplet (sneezing, coughing within 1 to 2 metres), vertical (mother to child during pregnancy or birth).

Indirect transmission. Vector-borne (Anopheles mosquito for malaria, Aedes aegypti for dengue), waterborne (Vibrio cholerae for cholera), foodborne (Salmonella for gastroenteritis), airborne (Mycobacterium tuberculosis on aerosols), fomite (objects contaminated with pathogens).

Portals of entry. Respiratory tract, gastrointestinal tract, urogenital tract, broken skin, bloodstream (needles, transfusions, mosquito bites), conjunctiva.

NESA likes diagrams of transmission cycles. A typical malaria cycle diagram shows the Anopheles mosquito as vector, sporozoites entering human blood during a bite, infecting liver cells, then erythrocytes, gametocytes returning to a feeding mosquito, and the cycle repeating.

The immune response

The immune system has two integrated arms.

Innate (non-specific) immunity. First line of defence, immediate.

• Physical barriers: skin, mucous membranes, cilia in respiratory tract.
• Chemical barriers: stomach acid (pH ~2), lysozyme in tears and saliva, antimicrobial peptides in sweat.
• Inflammation: damaged cells and mast cells release histamine; blood vessels vasodilate (redness, heat) and become more permeable (swelling); neutrophils and macrophages are recruited.
• Phagocytosis: macrophages and neutrophils engulf and digest pathogens.
• Natural killer cells: destroy virus-infected or cancerous cells.
• Complement system: cascade of plasma proteins that lyse pathogens, opsonise them for phagocytosis, and recruit inflammatory cells.

Adaptive (specific) immunity. Develops over days. Provides long-term memory.

• B lymphocytes. When a B cell's antigen receptor binds a specific antigen, the cell proliferates and differentiates into plasma cells (producing large quantities of antigen-specific antibodies) and memory B cells. Antibodies neutralise toxins, block pathogen-receptor binding, agglutinate pathogens, and mark them for phagocytosis (opsonisation).
• T lymphocytes. Cytotoxic T cells recognise infected cells displaying viral antigens on MHC class I molecules and kill them. Helper T cells recognise antigens on MHC class II molecules of antigen-presenting cells and release cytokines that coordinate the response.
• Memory cells. Long-lived populations of antigen-specific B and T cells that mount a faster, larger secondary response on re-exposure. This is the basis of vaccination.

A strong extended response can sketch this two-arm structure from memory and trace which cells respond to which pathogen type.

Epidemiology

Epidemiology is the study of disease distribution and determinants in populations. Core measures:

• Incidence: number of new cases per unit time per population.
• Prevalence: total cases at a point in time per population.
• Mortality rate: deaths per population per unit time.
• Case fatality rate: deaths among those infected.
• Basic reproductive number ($R_0$): average number of secondary infections from one primary case in a fully susceptible population. $R_0 > 1$ means outbreak grows; $R_0 < 1$ means it dies out.

Australian epidemiological case studies you can use include the long-running decline of tuberculosis since BCG vaccination and improved living standards; the near-elimination of indigenous cervical cancer through the HPV vaccination program; and the SARS-CoV-2 response (testing, contact tracing, border controls, mRNA vaccination).

Public health responses

NESA expects familiarity with the toolkit:

• Vaccination programs. Australia's National Immunisation Program funds free vaccines against more than a dozen diseases. The HPV program (introduced 2007 for girls, extended to boys 2013) has dramatically reduced cervical pre-cancer rates.
• Antibiotic stewardship. National programs to slow resistance.
• Quarantine and isolation. Quarantine restricts movement of exposed but healthy individuals; isolation separates the symptomatic.
• Contact tracing. Identifying and notifying people exposed to a confirmed case.
• Vector control. Removing breeding sites, insecticides, biological control.
• Sanitation and clean water. The single largest historical contributor to falling infectious disease mortality.
• Public education. Hand hygiene, safe sex, vaccination uptake.

Strong evaluative answers compare two strategies on at least three criteria: effectiveness, accessibility, ethics or social acceptability, and cost.

Antibiotic resistance

Resistance evolves when bacteria carrying random mutations conferring resistance survive antibiotic exposure and pass the gene on. Major mechanisms: enzymatic inactivation (beta-lactamases destroy penicillin); altered target (modified penicillin-binding proteins in MRSA); efflux pumps (active export of antibiotic); reduced permeability. Resistance genes spread within and between species via horizontal gene transfer (plasmids, transduction, transformation).

Drivers include over-prescription, patient non-adherence (incomplete courses), and routine agricultural use (livestock prophylaxis). Mitigation includes stewardship, surveillance, new drug development, phage therapy research, and reducing agricultural use.

How Module 7 is examined

A typical HSC Biology Module 7 exam profile:

• Multiple choice. 5 to 7 questions on pathogen recognition, transmission routes, immune cell function, epidemiological measures.
• Short answer (3 to 5 marks). Trace an immune response to a specific pathogen; calculate an incidence or prevalence value; describe a transmission cycle.
• Extended response (7 to 9 marks). Choose a named infectious disease, describe the pathogen and its mode of disease causation, describe the immune response, and evaluate one or more management strategies.

In one sentence

Module 7 rewards mastery of the five pathogen groups with named examples, the two-arm structure of the immune response, the core epidemiological measures, and the Australian public health toolkit; build the immune response diagram first, then the named cases, then the evaluative extended-response structure.